Advertisement

Peripheral Arterial Disease

  • Nages Nagaratnam
  • Kujan Nagaratnam
  • Gary Cheuk
Reference work entry

Abstract

This review provides an overview of peripheral arterial disease, the prevalence and mechanisms followed by management. The prevalence of symptomatic peripheral arterial disease (PAD) on average is about 5% at around 60 years of age. Atherosclerosis is by far the commonest pathological feature of PAD and accounts for more than 80% of PAD. The clinical manifestations of occlusive PAD are the result of ischaemia of the tissues supplied by the affected arteries and the character of pain related to the severity of the occlusion. The diagnosis in most instances can be confirmed by measuring the ankle-brachial index (ABI). Arterial duplex ultrasound, magnetic resonance angiography, segmental arterial pressure and digital subtraction angiography are useful in locating lesions in PAD. The scientific evidence strongly supports aggressive management of not only symptomatic atherosclerotic disease in terms of lifestyle intervention, lowering blood pressure, lowering lipids and controlling diabetes but also the management of individuals with high multifactorial risks.

Keywords

Peripheral arterial disease Atherosclerosis Rest pain Nocturnal pain Intermittent claudication Ankle-brachial index (ABI) 

References

  1. 1.
    Trans-Atlantic Inter-Society Consensus (TASC) on the management of peripheral arterial disease. Eur J Vasc Endovasc Surg. 2000; 19(Suppl A0 S1–S244.Google Scholar
  2. 2.
    Gey DC, Lesho EP, Manngold J. Management of peripheral arterial disease. Am Fam Physician. 2004;69(3):525–532.PubMedGoogle Scholar
  3. 3.
    The PARTNERS program. A national survey of peripheral arterial disease, detection, awareness and treatment. JAMA. 2001;286:1317–1324.CrossRefGoogle Scholar
  4. 4.
    Mahameed AAI. Peripheral Arterial Disease. Cleveland Clinic. www.clevelandclinicmeded.com/medical/pubs/disese management/caediology/peripheralarterial disease.
  5. 5.
    Hernando FJS, Conejero AM. Peripheral artery disease: Pathophysiology diagnosis and treatment. http://www.revescardiol.org/en/peripheral-artery-disease-pathophysiology-diagnosis/.Retrieved 12 January 2014.
  6. 6.
    Aronow WS. Management of peripheral arterial disease of the lower extremities. Compr Ther. 2007;33(4):247–56.CrossRefPubMedGoogle Scholar
  7. 7.
    Hamburg NM, Balady GJ. Exercise Rehabilitation in Peripheral Artery Disease. Circulation. 2011;123:87–97.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Bauer TA, Hiatt WR, Green S. Skeletal muscle metabolic changes in peripheral arterial disease contribute to exercise intolerance point – counterpoint discussion. Vasc Med. 2004;9:293–301.CrossRefGoogle Scholar
  9. 9.
    Hiatt WR. Medical treatment of peripheral arterial disease and claudication. NEJM. 2001;344:1608–21.CrossRefPubMedGoogle Scholar
  10. 10.
    Norman PE, Eikelboom JW, Hankey GJ. Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications. MJA. 2004;181:150–154.PubMedGoogle Scholar
  11. 11.
    Fowkes FGR. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol 1988;17:201–207.CrossRefGoogle Scholar
  12. 12.
    Ouriel K. Peripheral arterial disease Lancet.. 2001; 358(9289):1257–64.CrossRefPubMedGoogle Scholar
  13. 13.
    Wood DA, de Becker G, Faergeman O, Graham I, Manica G, Pyorala K. on behalf of the Task Force. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of the European Society of Cardiology, European Atherosclerotic Society and European Society of Hypertension. Eur Heart J. 1998;19:1434–1503.Google Scholar
  14. 14.
    Aronow WS. Medical treatment of peripheral arterial disease in the elderly. J Geriatr Cardiol. 2007;4(2):93–100.Google Scholar
  15. 15.
    Peach G, Griffin M, Jones KG, Thompson MM, Henchliffe RJ. Diagnosis and management of peripheral arterial disease. BMJ. 2012 345:e5208.CrossRefPubMedGoogle Scholar
  16. 16.
    Aronow WS. Management of peripheral arterial disease of the lower extremities in elderly patients. J Gerontol A Biol Sci Med Sci. 2004;59(2):172–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Tsai A, Folsom A, Rosamond W, Jones DW. Ankle-brachial index and 7-year ischaemic stroke incidence. The ARIC Study. Stroke. 2001;32:1721–1724.CrossRefPubMedGoogle Scholar
  18. 18.
    Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohi G, et al. Mortality and vascular abnormalities in older adults with asymptomatic versus symptomatic peripheral arterial disease. Circulation. 2009;12:2053–61.CrossRefGoogle Scholar
  19. 19.
    Leng GC, Fowkes FGR,Lee AJ, Denbar J, Housley E, Ruckley CV, et al. Use of ankle-brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ. 1996;313:1440–1444.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Newman A,Shemanski L, Manolic T, Cushman M, Mittelmark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19:538–545.CrossRefPubMedGoogle Scholar
  21. 21.
    Dormandy JA, Heeck L,Vig S. The fate of patients with critical leg ischaemia. SeminVasc Surg. 1999;12:142–147.Google Scholar
  22. 22.
    Bearley S. Acute leg ischaemia. Easily missed? BMJ. 2013;346:12681.Google Scholar
  23. 23.
    Angel D. Acute lower limb ischaemia: the challenge of patient care. Primary Intervention. 2003;11(11):38–44.Google Scholar
  24. 24.
    Norton C. Critical limb ischemia. Murray E. Vascular disease Nursing and Management. London. Whinrr 2001;270–312.Google Scholar
  25. 25.
    McPherson GAD, Wolfe JHN. Acute ischaemia of the Leg. ABC of vascular disease. BMJ. 1992; 304:169–172.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Tunis SR, Bass EB, Stenberg EP. The use of angioplasty, bypass surgery in the management of peripheral arterial disease. NEJM. 1991;325:556–563.CrossRefPubMedGoogle Scholar
  27. 27.
    Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs of peripheral arterial disease in the Medicare population.Vasc Med. 2008;13:209–215.CrossRefPubMedGoogle Scholar
  28. 28.
    Aronow WS,Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease and atherothrombotic brain infarctions in men and women=62 years of age. Am J Cardiol. 1994;74:64–65.CrossRefPubMedGoogle Scholar
  29. 29.
    Meijer W, Hoes A, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly. The Rotterdam study. Arterioscler Thromb Vasc Biol. 1998;18:185–192.CrossRefPubMedGoogle Scholar
  30. 30.
    Regensteiner JG, Hiatt WR, Coll JR, Criqui MH, Treat-Jacobson D, McDermott MB, et al. The impact of peripheral arterial disease in health related quality of life in the peripheral arterial disease awareness risk treatment: New Reasons for survival (PARTNERS) Program Vasc Med. 2008;13(1):15–24.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Nages Nagaratnam
    • 1
  • Kujan Nagaratnam
    • 1
  • Gary Cheuk
    • 2
  1. 1.The University of SydneyWestmead Clinical SchoolWestmeadAustralia
  2. 2.Rehabilitation and Aged Care ServiceBlacktown-Mt Druitt HospitalMount DruittAustralia

Personalised recommendations